A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).
Loganathan J, Cohen AC, Kaloupis GM, Harris C, Chronopoulos A, James V, Hamilton J, Green S, Wallis A, Morgan S, Dauer R, Gilfillan C, Dear AE.
Loganathan J, et al. Among authors: gilfillan c.
J Diabetes Complications. 2022 May;36(5):108188. doi: 10.1016/j.jdiacomp.2022.108188. Epub 2022 Mar 30.
J Diabetes Complications. 2022.
PMID: 35382966
Clinical Trial.